131 related articles for article (PubMed ID: 35768267)
1. Genetic features of TP53 mutation and its downstream FOXA1 in prostate cancer.
Xu X; Xie L; Meng L; Geng S; Liu J; Cao X; Dong Z; Xing Z
Biosci Trends; 2022 Jul; 16(3):221-229. PubMed ID: 35768267
[TBL] [Abstract][Full Text] [Related]
2. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
Parolia A; Cieslik M; Chu SC; Xiao L; Ouchi T; Zhang Y; Wang X; Vats P; Cao X; Pitchiaya S; Su F; Wang R; Feng FY; Wu YM; Lonigro RJ; Robinson DR; Chinnaiyan AM
Nature; 2019 Jul; 571(7765):413-418. PubMed ID: 31243372
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.
Jin HJ; Zhao JC; Ogden I; Bergan RC; Yu J
Cancer Res; 2013 Jun; 73(12):3725-36. PubMed ID: 23539448
[TBL] [Abstract][Full Text] [Related]
4. FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression.
Su Y; Zhang Y; Zhao J; Zhou W; Wang W; Han B; Wang X
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3225-3243. PubMed ID: 34258652
[TBL] [Abstract][Full Text] [Related]
5. The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer.
Lehrer S; Rheinstein PH
Discov Med; 2020; 30(161):163-171. PubMed ID: 33593484
[TBL] [Abstract][Full Text] [Related]
6. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
7. Pioneer of prostate cancer: past, present and the future of FOXA1.
Teng M; Zhou S; Cai C; Lupien M; He HH
Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
[TBL] [Abstract][Full Text] [Related]
8. Identification of critical pathways and hub genes in
Sun J; Zhang K; Cai Z; Li K; Zhao C; Fan C; Wang J
Biomark Med; 2019 Jul; 13(10):831-840. PubMed ID: 31116024
[No Abstract] [Full Text] [Related]
9. Unveiling the Molecular Landscape of
Hwang KW; Yun JW; Kim HS
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958805
[TBL] [Abstract][Full Text] [Related]
10. FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.
Imamura Y; Sakamoto S; Endo T; Utsumi T; Fuse M; Suyama T; Kawamura K; Imamoto T; Yano K; Uzawa K; Nihei N; Suzuki H; Mizokami A; Ueda T; Seki N; Tanzawa H; Ichikawa T
PLoS One; 2012; 7(8):e42456. PubMed ID: 22879989
[TBL] [Abstract][Full Text] [Related]
11. Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of
Guedes LB; Almutairi F; Haffner MC; Rajoria G; Liu Z; Klimek S; Zoino R; Yousefi K; Sharma R; De Marzo AM; Netto GJ; Isaacs WB; Ross AE; Schaeffer EM; Lotan TL
Clin Cancer Res; 2017 Aug; 23(16):4693-4703. PubMed ID: 28446506
[No Abstract] [Full Text] [Related]
12. Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.
Zhou S; Hawley JR; Soares F; Grillo G; Teng M; Madani Tonekaboni SA; Hua JT; Kron KJ; Mazrooei P; Ahmed M; Arlidge C; Yun HY; Livingstone J; Huang V; Yamaguchi TN; Espiritu SMG; Zhu Y; Severson TM; Murison A; Cameron S; Zwart W; van der Kwast T; Pugh TJ; Fraser M; Boutros PC; Bristow RG; He HH; Lupien M
Nat Commun; 2020 Jan; 11(1):441. PubMed ID: 31974375
[TBL] [Abstract][Full Text] [Related]
13. FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer.
Gerhardt J; Montani M; Wild P; Beer M; Huber F; Hermanns T; Müntener M; Kristiansen G
Am J Pathol; 2012 Feb; 180(2):848-61. PubMed ID: 22138582
[TBL] [Abstract][Full Text] [Related]
14. TP53 structural variants in metastatic prostatic carcinoma.
Sirohi D; Devine P; Grenert JP; van Ziffle J; Simko JP; Stohr BA
PLoS One; 2019; 14(6):e0218618. PubMed ID: 31216325
[TBL] [Abstract][Full Text] [Related]
15. Forkhead‑box A1 regulates tumor cell growth and predicts prognosis in colorectal cancer.
Park YL; Kim SH; Park SY; Jung MW; Ha SY; Choi JH; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
Int J Oncol; 2019 Jun; 54(6):2169-2178. PubMed ID: 31081047
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of FOXA1 with the malignancy and progression of prostate cancer].
Feng W; Zhang HB; Wang YM; Hu JL
Zhonghua Nan Ke Xue; 2015 May; 21(5):414-9. PubMed ID: 26117938
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of forkhead box protein A1 and its role in colorectal cancer.
Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q
Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093
[TBL] [Abstract][Full Text] [Related]
18. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
19. SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.
Hernández-Llodrà S; Segalés L; Safont A; Juanpere N; Lorenzo M; Fumadó L; Rodríguez-Vida A; Cecchini L; Bellmunt J; Lloreta-Trull J
Prostate; 2019 Jul; 79(10):1156-1165. PubMed ID: 31090082
[TBL] [Abstract][Full Text] [Related]
20. FOXA1 regulates ribosomal RNA transcription in prostate cancer.
Jia T; Liu C; Guo P; Xu Y; Wang W; Liu X; Wang S; Zhang X; Guo H
Prostate; 2024 Jul; 84(10):967-976. PubMed ID: 38632701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]